Reshaping Tuberculosis Disease Market Vertical with DLI's Drug Insights, Regulatory Consulting, and Clinical Trial Management Services | Disease Landscape Insights

StreetInsider2023-10-11

LONDON, Oct. 11, 2023 /PRNewswire/ -- Tuberculosis is a global health concern affecting a large proportion of the world population. According to epidemiology study by World Health Organization, every ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2374646749?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-10-11 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2374646749","market":"us","top_or_hot":-1,"title":"Reshaping Tuberculosis Disease Market Vertical with DLI's Drug Insights, Regulatory Consulting, and Clinical Trial Management Services | Disease Landscape Insights","media":"StreetInsider","content":"<div>\n<p>LONDON, Oct. 11, 2023 /PRNewswire/ -- Tuberculosis is a global health concern affecting a large proportion of the world population. According to epidemiology study by World Health Organization, every ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=22261778\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reshaping Tuberculosis Disease Market Vertical with DLI's Drug Insights, Regulatory Consulting, and Clinical Trial Management Services | Disease Landscape Insights</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReshaping Tuberculosis Disease Market Vertical with DLI's Drug Insights, Regulatory Consulting, and Clinical Trial Management Services | Disease Landscape Insights\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-11 22:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=22261778><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>LONDON, Oct. 11, 2023 /PRNewswire/ -- Tuberculosis is a global health concern affecting a large proportion of the world population. According to epidemiology study by World Health Organization, every ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=22261778\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=22261778","article_id":"2374646749","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2374646749","pubTimestamp":1697035500,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"LONDON, Oct. 11, 2023 /PRNewswire/ -- Tuberculosis is a global health concern affecting a large proportion of the world population. According to epidemiology study by World Health Organization, every day close to 4400 people lose their lives to TB and close to 30,000 people fall ill every single day. This high disease burden is pushing government bodies, healthcare experts, and welfare organizations to emphasize on eradicating or at least minimizing the prevalence of this dreadful ailment.Tuberculosis  is bacterial infection that predominantly affects the lungs. Mycobacterium tuberculosis is the bacterium responsible for the occurrence of this disease. Apart from the respiratory system TB also starts impacting other organs, leading to severe complications and even death. It is a contagious disorder and TB transmission may occur via the inhalation of droplets that get released in the air when an infected person sneezes, coughs, or even talks.","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","EMB":"新兴市场美元债ETF-iShares","PZA":"免AMT市政债ETF-PowerShares"},"translate_title":"利用DLI的药物洞察、监管咨询和临床试验管理服务疾病景观洞察重塑结核病垂直市场","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMB":1,"PZA":1},"content_text":"LONDON, Oct. 11, 2023 /PRNewswire/ -- Tuberculosis is a global health concern affecting a large proportion of the world population. According to epidemiology study by World Health Organization, every day close to 4400 people lose their lives to TB and close to 30,000 people fall ill every single day. This high disease burden is pushing government bodies, healthcare experts, and welfare organizations to emphasize on eradicating or at least minimizing the prevalence of this dreadful ailment.\n\n\n\n\n\nTuberculosis (TB) is bacterial infection that predominantly affects the lungs. Mycobacterium tuberculosis is the bacterium responsible for the occurrence of this disease. Apart from the respiratory system TB also starts impacting other organs, leading to severe complications and even death. It is a contagious disorder and TB transmission may occur via the inhalation of droplets that get released in the air when an infected person sneezes, coughs, or even talks.\nContinuous R&D activities are being conducted with an aim to develop high advanced tuberculosis treatment solutions. DLI has been a forefront in assisting the players in their drug development endeavours. The Tuberculosis Disease Market players procure DLI's healthcare consulting services to accelerate various activities. DLI helps them with treatment gaps identification, clinical trial feasibility analysis, commercial strategy analysis, drug launch strategies, along with pricing and market access decisions.\nPrice and Market Access\nTuberculosis Disease- Causes and Symptoms:\nAs described, this disease is caused by the bacterium Mycobacterium tuberculosis. Apart from that, coming in close contact with infected person, excessive smoking, exposure to environmental irritants, and harmful chemical may also trigger this disorder.\nIt is worth noting that there is another form of this ailment known as Latent TB infection. Here the bacteria can enter the body but remain dormant, causing no symptoms. Pulmonary TB and extra-pulmonary TB are two other sub types of this disease.\nThe primary symptoms of TB are persistent cough, fatigue, blood droplets with cough, weight loss, fever and chills, swollen lymph nodes, and shortness of breath, among others. It is advisable to consult a TB specialist when a person experience any of these symptoms for a long duration. Numerous TB clinics have been set up in both rural and urban areas across the globe so as to accelerate TB diagnosis and reduce the risk of complications.\nDiscover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @\nhttps://www.diseaselandscape.com/downloadsample/postid/7\nDiagnostic and Treatment Landscape:\nEarly diagnosis of this disease is nothing less than a boon for patients. It not only increases their life span but also reduce the chances of hospitalization. Proper TB healthcare can be provided to the patients if it is diagnosed at its initial stage. TB screening, clinical evaluation, chest x-ray, Mantoux test, sputum culture, and biopsy, among others are some of the efficient diagnostic treatments.\nThe treatment vertical for this infection is vast. Numerous affordable TB drugs have been introduced to reduce the economic disparity among the masses when it comes to quality healthcare access. Reduced TB treatment costs across various regions are enabling people with low-income levels to easily buy TB medication. Isoniazid (INH), Rifampin (RIF), Pyrazinamide (PZA), Ethambutol (EMB) are some of the most commonly prescribed TB drugs. It is also worth mentioning that TB prevention is crucial for the people right from an early stage. For that effective TB vaccines have been developed by leading pharma companies that has significantly contributed to the decreased burden of TB worldwide.\nUnlock the Benefits Today! Get Started Now and Elevate Your Experience @\nhttps://www.diseaselandscape.com/checkout?report_id=7\nFinal Words:\nTuberculosis infection is a menace that has claimed millions of lives worldwide. It took the form of a global health crisis a few decades back. Government bodies and healthcare research organizations made joint efforts to develop effective treatment entities against this ailment. DLI has been offering pharma consulting services to the drug and vaccine developers to help them with product portfolio extension, price reimbursement, product pipeline analysis, and post launch services, among others. With these efforts, they are trying to enhance the quality of life of TB patients and their caregivers.\nBrowse Through More Infectious Diseases Research Reports.\nRelated Reports:\nLaunch of a Medical High-Tech Innovation Case Study\nCase Analysis: Development of an Antibiotic\nCase Study: Using Emerging Technologies to Discover Antiallergic Drugs\nCase Study: Creation and Submission of a New Drug Application (NDA)\nCase Study: Trends in API Prices\nCollaboration with Commercial Laboratories to Develop Monkeypox Detection Technologies to Support Business Growth\nFor lung cancer treatment, radiation is employed.\nImmunomodulating Drugs for Lupus\nTo Launch More Affordable Drugs and Boost Productivity Through Cost-Effective Research and Development\nFinding a Hemophilia Treatment Facility that Accepts\nLaunch of a Pneumonia Diagnostic Tool in the Market\nCase Study: Clinical Trials for Parkinson's Disease Project Management\nCase Study: The Pancreatic Cancer Treatment Landscape is Changing\nCase Study: Examining Topical Medicines for Treatment of Psoriasis\nCase Study: The Benefits of an Combination for Alzheimer's Drug\nCase Study: Vaccine Development\nA case study involving the cooperation of a pharmaceutical business with CDMOs and SMOs\nCase Study: Expansion of the Australian Product Portfolio\nAI application in a healthcare organization: a case study\nCase Study: Landscape Analysis of Ovarian Cancer Treatment\nAbout Disease Landscape:  \nDisease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  \nOur core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  \nContact Us:  Disease Landscape Insights LLP  6th Floor, Sr No.207, Office A H 6070 Phase 1  Solitaire Business Hub, Viman Nagar  Pune, Maharashtra, 411014. Sales Contact: +44-2038074155  Asia Office Contact: +917447409162 Email: [email protected]Email: [email protected] Blog: https://www.diseaselandscape.com/blogs Case Study: https://www.diseaselandscape.com/casestudies    Pharma consulting Services  Follow Us: LinkedIn | Twitter | Facebook \nLogo: https://mma.prnewswire.com/media/2217060/Disease_Landscape_Insights_Logo.jpg\n View original content to download multimedia:https://www.prnewswire.com/news-releases/reshaping-tuberculosis-disease-market-vertical-with-dlis-drug-insights-regulatory-consulting-and-clinical-trial-management-services--disease-landscape-insights-301953734.html\nSOURCE Disease Landscape Insights","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2374646749"}